BIOSPECIMEN360 Trademark

Trademark Overview


On Friday, July 26, 2024, a trademark application was filed for BIOSPECIMEN360 with the United States Patent and Trademark Office. The USPTO has given the BIOSPECIMEN360 trademark a serial number of 98669048. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, February 21, 2025. This trademark is owned by Slope.io, Inc.. The BIOSPECIMEN360 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring computer software platforms for use in database management in the field of clinical trials; software as a service (SAAS) services featuring computer software platforms to provide clinical trial sponsors with compliant, structured, and traceable sample data to inform timely study decisions; software as a service (SAAS) services featuring computer software platforms for use in database management in the field of clinical trials that enable automated, real-time inventory management, automated lab kit resupply, sample collection workflows, intelligent sample-to-lab and lab-to-lab routing, resupply for and chain of custody of clinical trial drugs, devices, and equipment, and access to stakeholders in the clinical trial ecosystem, namely, trial sponsors, contract research organizations, research sites, vendors, patients, and laboratories; consulting services for others in the field of design, planning, and implementation project management of c...
biospecimen360

General Information


Serial Number98669048
Word MarkBIOSPECIMEN360
Filing DateFriday, July 26, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, February 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIOSPECIMEN THREE HUNDRED SIXTY
Pseudo MarkBIOSPECIMEN THREE SIX ZERO
Goods and ServicesSoftware as a service (SAAS) services featuring computer software platforms for use in database management in the field of clinical trials; software as a service (SAAS) services featuring computer software platforms to provide clinical trial sponsors with compliant, structured, and traceable sample data to inform timely study decisions; software as a service (SAAS) services featuring computer software platforms for use in database management in the field of clinical trials that enable automated, real-time inventory management, automated lab kit resupply, sample collection workflows, intelligent sample-to-lab and lab-to-lab routing, resupply for and chain of custody of clinical trial drugs, devices, and equipment, and access to stakeholders in the clinical trial ecosystem, namely, trial sponsors, contract research organizations, research sites, vendors, patients, and laboratories; consulting services for others in the field of design, planning, and implementation project management of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSlope.io, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events


Event DateEvent Description
Friday, July 26, 2024NEW APPLICATION ENTERED
Sunday, February 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 17, 2025ASSIGNED TO EXAMINER
Thursday, February 20, 2025NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025NON-FINAL ACTION WRITTEN
Thursday, February 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED